Professor Michael Berk

Wednesday 13 September
Plenary 9: The Australian Society of Bipolar and Depressive Disorder (ASBDD) Symposium

Disease-modifying agent in psychiatry: which, when and how

Professor Michael Berk is currently a NHMRC Senior Principal research Fellow and is Alfred Deakin Chair of Psychiatry at Deakin University and Barwon Health, where he heads the Institute for Innovation in Mental and Physical Health and Clinical Translation (IMPACT).

He also is an Honorary Professorial Research fellow in the Department of Psychiatry, the Florey Institute for Neuroscience and Mental Health and Orygen Youth Health at Melbourne University, as well as in the School of Public Health and Preventive Medicine at Monash University.

He has published over 1400 papers and is listed by Thompson Reuters ISI as highly cited (2015-2022).
He has been awarded over $147M in grant funding. His major interests are in the discovery and implementation of novel therapies.